Phosphocysteamine (BioDeep_00000840965)
代谢物信息卡片
化学式: C2H8NO3PS (156.9962508)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C(CSP(=O)(O)O)N
InChI: InChI=1S/C2H8NO3PS/c3-1-2-8-7(4,5)6/h1-3H2,(H2,4,5,6)
描述信息
D020011 - Protective Agents > D011837 - Radiation-Protective Agents
同义名列表
1 个代谢物同义名
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Naïm Bouazza, Jean-Marc Tréluyer, Chris Ottolenghi, Saik Urien, Georges Deschenes, Daniel Ricquier, Patrick Niaudet, Bernadette Chadefaux-Vekemans. Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.
Orphanet journal of rare diseases.
2011 Dec; 6(?):86. doi:
10.1186/1750-1172-6-86. [PMID: 22195601] - Z Zhang, J D Butler, S W Levin, K E Wisniewski, S S Brooks, A B Mukherjee. Lysosomal ceroid depletion by drugs: therapeutic implications for a hereditary neurodegenerative disease of childhood.
Nature medicine.
2001 Apr; 7(4):478-84. doi:
10.1038/86554. [PMID: 11283676] - F K Assadi, P McCue, S Jefferis, M Shi, D A Beckman. Effects of pre- and postnatal cysteamine exposure on renal function in the rat.
Pediatric nephrology (Berlin, Germany).
1999 Nov; 13(9):812-5. doi:
10.1007/s004670050706. [PMID: 10603127] - M Fischbach, J Terzic, A Cavalier, P Mambrini, J Geisert. Renal stones in nephropathic cystinosis treated with phosphocysteamine.
Pediatric nephrology (Berlin, Germany).
1997 Dec; 11(6):787-8. doi:
NULL. [PMID: 9438669] - W G van't Hoff, N Gretz. The treatment of cystinosis with cysteamine and phosphocysteamine in the United Kingdom and Eire.
Pediatric nephrology (Berlin, Germany).
1995 Dec; 9(6):685-9. doi:
10.1007/bf00868711. [PMID: 8747105] - W A Gahl, J G Thoene, J A Schneider, S O'Regan, M I Kaiser-Kupfer, T Kuwabara. NIH conference. Cystinosis: progress in a prototypic disease.
Annals of internal medicine.
1988 Oct; 109(7):557-69. doi:
10.7326/0003-4819-109-7-557. [PMID: 3048161] - L A Smolin, K F Clark, J G Thoene, W A Gahl, J A Schneider. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis.
Pediatric research.
1988 Jun; 23(6):616-20. doi:
10.1203/00006450-198806000-00018. [PMID: 3393396] - G F Zheleznikova, R P Ogurtsov, A N Stepanov. [Stimulating effect of aminoethylisothiuronium on the immune response and interferonogenesis in irradiated mice].
Radiobiologiia.
1985 Jan; 25(1):95-9. doi:
NULL. [PMID: 3975380] - A G Khaitovich, E A L'vovskii. [Dynamics of production and various properties of interferon-like inhibitors formed under the influence of AET and cystaphos in vivo and in cell cultures].
Voprosy virusologii.
1975 Mar; ?(2):183-6. doi:
NULL. [PMID: 3884]